This Blood Pressure Drug Is Now Approved for a Rare Kidney Condition
In April 2025, the FDA granted accelerated approval to Vanrafia (atrasentan), a blood pressure drug now cleared to treat IgA nephropathy, a rare kidney...
Category Tools
New Severe Asthma Biologic Approved for 12-Year-Olds
The FDA approved Exdensur (depemokimab-ulaa) on December 16, 2025, making it the first ultra-long-acting biologic available for severe eosinophilic asthma...
New Drug for Moderate-to-Severe Plaque Psoriasis Approved in Record Time
The FDA today approved ICOTYDE (icotrokinra), the first oral pill that targets the IL-23 pathway for moderate-to-severe plaque psoriasis, marking a...
This Intranasal Drug Is Changing How Seizures Are Treated at Home
Two FDA-approved intranasal sprays — Nayzilam (midazolam) and Valtoco (diazepam) — are fundamentally changing how seizure clusters are managed outside of...
Why Some Antifungal Drugs Require Liver Monitoring Every Month
Some antifungal drugs require monthly liver monitoring because they are metabolized through the liver's cytochrome P450 enzyme system, and that metabolic...
New Drug for Systemic Mastocytosis Approved After Years of No Options
After decades with no targeted treatments, patients with systemic mastocytosis finally have real pharmaceutical options — and the pipeline is still...
This Diabetes Drug Is Now Approved for Heart Failure Without Diabetes
A class of drugs originally designed to lower blood sugar in people with type 2 diabetes has crossed into entirely new territory — and the implications...
New Antibiotic Gel Approved for Gonorrhea — Addressing Resistance
In December 2025, the FDA approved two new oral antibiotics for gonorrhea — the first new treatments for the infection in nearly two decades.
Why Patients Are Being Warned About Buying Medication From Online Pharmacies
Patients are being warned about buying medication from online pharmacies because the vast majority of these websites are illegal operations that sell...
New Weight Loss Injectable Approved for Adolescents — First of Its Kind
In August 2025, the FDA approved the first-ever generic GLP-1 receptor agonist specifically indicated for weight loss — Teva Pharmaceuticals' generic...